Repository

Publications

A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index

Persano M, Rimini M, Salani F, Prinzi FL, Nichetti F, Saborowski A, Antonuzzo L, Passeri L, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Corallo S, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Fornaro L, De Rosa A, Lanzetta I, Balsano R, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Tesini G, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Ferrara M, Himmelsbach V, Landriscina M, Djaballah SA, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A.
Liver Int. 2025 Jul;45(7):e70181. doi: 10.1111/liv.70181.
2025 

Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancement

Carpino G, Overi D, Macias RI, Cardinale V, Izquierdo-Sanchez L, Acedo P, Rengo M, Doukas M, Kendall TJ, Calderaro J, Heij LR, Reichel K, Leone S, Onori P, Franceschini B, Soldani C, Di Tommaso L, Rodrigues PM, Augustin J, Brustia R, Torzilli G, Martin-Izquierdo M, Hernández-Bayo JM, Bueno-Sacristan D, Lanza E, Garcia-Sampedro A, Quaglia A, Ardito F, De Rose AM, Giuliante F, Damato E, Panebianco V, Groot Koerkamp B, Pereira SP, Grazi GL, Alvaro D, Lleo A, Banales JM, Gaudio E
Hepatology. 2025 Jun 16. doi: 10.1097/HEP.0000000000001425
2025 
Funded by  

Modulating Wnt/β-catenin pathway activity to enhance chemosensitivity in cholangiocarcinoma

Delgado-Calvo K, Boulter L, Briz O, Rozyczko A, Olaizola P, Marin JJG, Macias RIR, Lozano E
Biomed Pharmacother. 2025 Jun 4;188:118225. doi: 10.1016/j.biopha.2025.118225
2025 

Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study

Rimini M, Fornaro L, Prinzi FL, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Salani F, De Rosa A, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Corallo S, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Vitiello F, Himmelsbach V, Landriscina M, Djaballah SA, Tesini G, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A.
Int J Cancer. 2025 May 19. doi: 10.1002/ijc.35481.
2025 

Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques

Singh Y, Andersen JB, Hathaway Q, Venkatesh SK, Gores GJ, Erickson B
Oncotarget. 2025 Apr 4;16:249-255. doi: 10.18632/oncotarget.28709
2025 
Results from  
Join the Action
JOIN